Katie B. Ryan

1.2k total citations
24 papers, 904 citations indexed

About

Katie B. Ryan is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Katie B. Ryan has authored 24 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Biomedical Engineering and 6 papers in Biomaterials. Recurrent topics in Katie B. Ryan's work include Bone Tissue Engineering Materials (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Sphingolipid Metabolism and Signaling (5 papers). Katie B. Ryan is often cited by papers focused on Bone Tissue Engineering Materials (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Sphingolipid Metabolism and Signaling (5 papers). Katie B. Ryan collaborates with scholars based in Ireland, United States and Egypt. Katie B. Ryan's co-authors include Abina M. Crean, Robert J. Ahern, Christian Waeber, Carol A. McCarthy, Ronan MacLoughlin, Paul Galvin, Conor S. Burke, Yurii K. Gun’ko, Yuri Volkov and John P. Hanrahan and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Katie B. Ryan

21 papers receiving 887 citations

Peers

Countries citing papers authored by Katie B. Ryan

Since Specialization

Citations

This map shows the geographic impact of Katie B. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie B. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie B. Ryan more than expected).

Fields of papers citing papers by Katie B. Ryan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie B. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie B. Ryan. The network helps show where Katie B. Ryan may publish in the future.

Co-authorship network of co-authors of Katie B. Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Katie B. Ryan. A scholar is included among the top collaborators of Katie B. Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie B. Ryan. Katie B. Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Impact of protein adsorption during biopharmaceutical manufacture & storage	European Journal of Pharmaceutical Sciences	Abina M. Crean, Katie B. Ryan et al.	0
2	Pulmonary delivery of siRNA lipoplexes and lipid nanoparticles using a vibrating mesh nebuliser	European Journal of Pharmaceutical Sciences	Ronan MacLoughlin, Piotr S. Kowalski et al.	0
3	Early Onset Sepsis	Pediatric Clinics of North America	Katie B. Ryan et al.	0
4	In Vivo Ocular Pharmacokinetics and Toxicity of Siponimod in Albino Rabbits	Molecular Pharmaceutics	Christian Waeber, Katie B. Ryan et al.	1
5	Extended siponimod release via low-porosity PLGA fibres: a comprehensive three-month in vitro evaluation for neovascular ocular diseases	Biomaterials Science	Christian Waeber, Katie B. Ryan et al.	1
6	Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol	Journal of Controlled Release	Piotr S. Kowalski, Ronan MacLoughlin et al.	26
7	Siponimod As a Novel Inhibitor of Retinal Angiogenesis: In Vitro and In Vivo Evidence of Therapeutic Efficacy	Journal of Pharmacology and Experimental Therapeutics	Katie B. Ryan, Christian Waeber et al.	4
8	Nano-Hydroxyapatite/PLGA Mixed Scaffolds as a Tool for Drug Development and to Study Metastatic Prostate Cancer in the Bone	Pharmaceutics	Caitríona M. O’Driscoll, Katie B. Ryan et al.	6
9	Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies	Advanced Drug Delivery Reviews	Christian Waeber, Katie B. Ryan et al.	74
10	Osteointegration, antimicrobial and antibiofilm activity of orthopaedic titanium surfaces coated with silver and strontium-doped hydroxyapatite using a novel blasting process	Drug Delivery and Translational Research	Abina M. Crean, Katie B. Ryan et al.	21
11	Sphingosine 1-phosphate, a potential target in neovascular retinal disease	British Journal of Ophthalmology	Katie B. Ryan, Christian Waeber et al.	13
12	Bone regenerative potential of the selective sphingosine 1-phosphate receptor modulator siponimod: In vitro characterisation using osteoblast and endothelial cells	European Journal of Pharmacology	Ziad Sartawi, Katie B. Ryan et al.	7
13	Development of electrospun polymer scaffolds for the localized and controlled delivery of siponimod for the management of critical bone defects	International Journal of Pharmaceutics	Ziad Sartawi, Christian Waeber et al.	9
14	Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair	Pharmacological Research	Ziad Sartawi, Ernestina Schipani et al.	28
15	In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation	Journal of Controlled Release	Carol A. McCarthy, Waleed Faisal et al.	28
16	Mesoporous silica formulation strategies for drug dissolution enhancement: a review	Expert Opinion on Drug Delivery	Carol A. McCarthy, Robert J. Ahern et al.	158
17	Comparison of fenofibrate–mesoporous silica drug-loading processes for enhanced drug delivery	European Journal of Pharmaceutical Sciences	Robert J. Ahern, John P. Hanrahan et al.	100
18	The influence of supercritical carbon dioxide (SC-CO2) processing conditions on drug loading and physicochemical properties	International Journal of Pharmaceutics	Robert J. Ahern, Abina M. Crean et al.	31
19	Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications	Cellular and Molecular Life Sciences	Paul Galvin, Damien Thompson et al.	80
20	Deposition of substituted apatites with anticolonizing properties onto titanium surfaces using a novel blasting process	Journal of Biomedical Materials Research Part B Applied Biomaterials	Caroline O’Sullivan, P. O’Hare et al.	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact